إعلان
إعلان
VRTX
Vertex Pharmaceuticals Inc
469.71
USDبرعاية
-14.44
-2.98%
٠٨ يناير, ١٦:٠٠ UTC -5
مغلق
بعد الإغلاق
470.26
+0.55
+0.12%
تقارير أرباح VRTX
النسبة الإيجابية المفاجئة
VRTX تفوق 30 من 39 آخر التقديرات.
77%
التقرير التالي
بيانات التقرير القادم
٠٤ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$3.24B
/$5.20
التغير الضمني من Q3 25 (Revenue/ EPS)
+5.43%
/+8.33%
التغير الضمني من Q4 24 (Revenue/ EPS)
+11.39%
/+30.65%
Vertex Pharmaceuticals Inc earnings per share and revenue
On ٠٣ نوفمبر ٢٠٢٥, VRTX reported earnings of 4.80 USD per share (EPS) for Q3 25, beating the estimate of 4.65 USD, resulting in a 3.12% surprise. Revenue reached 3.08 مليار, compared to an expected 3.11 مليار, with a -1.22% difference. The market reacted with a -1.02% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 31 المحللين forecast an EPS of 5.20 USD, with revenue projected to reach 3.24 مليار USD, implying an زيادة of 8.33% EPS, and زيادة of 5.43% in Revenue from the last quarter.
الأسئلة الشائعة
What were Vertex Pharmaceuticals Inc's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Vertex Pharmaceuticals Inc reported EPS of $4.80, beating estimates by 3.12%, and revenue of $3.08B, -1.22% below expectations.
How did the market react to Vertex Pharmaceuticals Inc's Q3 2025 earnings?
The stock price moved down -1.02%, changed from $426.00 before the earnings release to $421.67 the day after.
When is Vertex Pharmaceuticals Inc expected to report next?
The next earning report is scheduled for ٠٤ فبراير ٢٠٢٦.
What are the forecasts for Vertex Pharmaceuticals Inc's next earnings report?
Based on 31
المحللين, Vertex Pharmaceuticals Inc is expected to report EPS of $5.20 and revenue of $3.24B for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان